NINDS Neuroscience Funding Announcements

Skip secondary menu

New Information from NINDS Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.



Acceleration of Neuroprotective Agents/Therapeutics Development and Optimization of Information for Parkinson's Disease; (Formerly entitled, "Committee to Identify Neuroprotective Agents for Parkinson's (CINAPS) Drug Optimization Program")
Release Date: January 17, 2006
Announcement Number: RFP-NIH-NINDS-06-02
Proposal Receipt Date: March 17, 2006   

Funding Contact: Helene Braun
Program Area: Neurodegeneration, Contracts Management Branch
Amendments: Amendment #1, Amendment #2, Amendment #2 (Page 3 of 3)

Brief Description:
The objective of this contract is to accelerate neuroprotective therapeutics development for Parkinson’s disease (PD). PD is the second most commonly occurring neurodegenerative disease, hallmarked by the gradual loss of dopaminergic and other neurons, as well as the accumulation of insoluble aggregates. Therefore, a primary goal is to find rational treatments which can prevent progression of the disease once diagnosed, or prevent neurons from dying in individuals at risk for developing disease. It is anticipated that the award from this solicitation will be a cost reimbursement contract.

Choose an option to view additional funding announcements
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives